Binary analysis of MGMT promotor methylation with MSP showed comparable methylation rates with 48.4% methylation in the entire cohort, 47.8% in histopathological GBM, and 50.9% in molecular GBM (p = 0.675) (Fig. 1A). This evidence concerns the gene MGMT and glioblastoma.